ORLISTAT 120mg. IP

An anti-obesity medication is employed for weight loss in obese patients. (Suyog S. Jain, 2011) A lipase inhibitor that reduces fat absorption from the intestines, prevents absorption of fat significantly. (Suyog S. Jain, 2011) Lessens weight by around 3 kg on average and decreases progression to diabetes in high-risk patients. (Raj S Padwal, 2007) A powerful inhibitor of gastrointestinal lipase that reduces body weight by inhibiting absorption (by approximately 30%) of ingested dietary fat. (K H Lucas, 2001) A beneficial approach for patients with comorbid conditions related to obesity, such as diabetes and hyperlipidemia. (K H Lucas, 2001) A valuable agent that attenuates weight regain, and improves obesity-related disease risk factors in obese subjects. (M H Davidson, 1999) A well-tolerated agent that offers a promising new approach to the long-term management of obesity. (N Finer, 2000) An effective medicament in obese diabetic patients. (A Halpern, 2003) Significantly promotes weight loss, improves glycemic control and lipid profile. (A Halpern, 2003) An effective adjunctive therapy to lifestyle modifications in the treatment of obesity. (N M Aldekhail, 2015)